PDT Partners, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 141 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,172,375
-64.0%
37,077
+52.6%
0.15%
-36.8%
Q3 2021$3,260,000
-60.7%
24,300
-52.5%
0.23%
-57.3%
Q2 2021$8,290,000
+91.5%
51,200
-5.1%
0.55%
+76.2%
Q1 2021$4,329,000
-12.0%
53,937
-40.3%
0.31%
-6.3%
Q4 2020$4,918,000
+196.3%
90,400
+8.3%
0.33%
+201.8%
Q3 2020$1,660,000
-22.7%
83,509
-18.2%
0.11%
-24.7%
Q2 2020$2,147,000
+70.3%
102,143
-0.9%
0.15%
+46.0%
Q1 2020$1,261,000
+0.5%
103,100
+20.6%
0.10%
+29.9%
Q4 2019$1,255,000
+61.5%
85,517
+46.9%
0.08%
+67.4%
Q3 2019$777,000
-18.6%
58,200
-0.2%
0.05%
-17.9%
Q2 2019$954,000
-20.4%
58,288
-33.6%
0.06%
-16.4%
Q4 2018$1,198,000
-52.3%
87,743
+0.0%
0.07%
-35.6%
Q3 2018$2,511,000
-13.8%
87,726
-17.6%
0.10%
-6.3%
Q2 2018$2,914,000
+19.9%
106,509
-7.6%
0.11%
+35.4%
Q1 2018$2,431,000115,2540.08%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 744,160$54,078,0005.79%
Discovery Value Fund 986,173$71,665,0005.28%
Ally Bridge Group (NY) LLC 60,000$4,360,0003.23%
MPM BioImpact LLC 159,409$11,584,0003.11%
ARK Investment Management 8,981,029$652,651,0002.72%
Elmwood Wealth Management, Inc. 67,599$4,912,0002.52%
Nikko Asset Management Americas, Inc. 2,872,269$192,442,0001.41%
Frazier Life Sciences Management, L.P. 203,684$14,802,0001.26%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$8,098,0001.22%
Merlin Capital, Inc 11,575$841,0001.11%
View complete list of INTELLIA THERAPEUTICS INC shareholders